According to the latest research by InsightAce Analytic, the global Asthma Spacers market is valued at US$ 1.51 Billion in 2021, and it is expected to grow with a CAGR of 5.9% during a forecast period of 2022-2030. Spacers are a plastic tubes specifically designed to act as an interface between the pressurized metered-dose inhalers and patients. Spacers are also known as valved holding chanmber (VHC). The Spacers attaches to a pressurized metered-dose inhaler at one end and to the other end has mouthpiece to breathe through. The use of a spacer decreases the risk of drug underdose, minimizes oropharyngeal deposition and improves the amount of medication reaching to lungs. Spacers make pressurized metered dose inhalers (pMDI) comfortable to use by decreasing or eliminating the requirement for proper coordination between actuation and inhalation. The spacer helps proper delivery of drug by reducing the cold Freon effect. However, the benefits of spacers are offered at the cost of making pMDI system significantly large and less convenient. In general, spacers are categorized into Reverse-flow devices, Holding chambers, and Simple tube extensions to the actuator mouthpiece.
The asthma spacers market is segment based on brand, application, and geography. In terms of product the global market is segregated into Space Chamber Plus, A2A Spacer, Flo-Tone CR, Able Spacer, AeroChamber, Volumatic, Vortex, OptiChamber. High R&D activities and rising adoption rate for Spacer are the major factor that drives the growth of the market. The market players are highly active in delivering value products complying the customer need. The companies in the asthma spacers market invest considerably in research and development activities to develop highly advanced products. Increasing awareness about the new technology through multi-channel marketing and activities has led to an increase in demand for the new products.
Based on application, the market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies. Based on geography, the global asthma spacers market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of revenue, Europe followed by North America is the major contributor for the global asthma spacers market. According to WHO report 2018, approximately 334 million are suffering from asthma. Various government initiatives and activities carried global organisations has raised healthcare accessibility deeper in the worldwide market. Rising awareness about asthma treatment, growing market access to the drugs, increase in purchasing power of an individual are the key components fostering the asthma spacers market to propel substantially. Increasing research and development activities performed by industry players, has been fostering innovations in the product offerings. Due advancements in the product offerings have resulted in an increase in market demand for asthma spacers for respiratory treatment.
Some of the market players leading the global asthma spacer market include Medical Development International, Trudell Medical International, Pari GmbH, Conmed Corporation, GlaxoSmithKline, Merck & Co., Inc, Koninklijke Philips N.V, AstraZeneca, Cipla, Clement Clarke, Lupin, Fisons, Bird Healthcare, InspiRX Inc. and many more.